Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Severe drug eruption (L27.900x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Dermatitis due to ingested substances (L27.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Arsenic-allergy dermatitis (L27.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other dermatitis due to ingested substances (L27.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Milk-allergy dermatitis (L27.201) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Dermatitis due to ingested food (L27.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Fixed drug eruption is recurrent well-demarcated violaceous plaque at same site on re-exposure; stop culprit, topical steroids, antihistamines, hypopigmentation may persist.
皮肤科Localized rash due to drugs/medicaments (L27.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Drug eruption is cutaneous reaction to systemic drug; stop culprit, supportive care, topical/systemic steroids, antihistamines, monitor severe reactions (SJS/TEN/DRESS/AGEP).
皮肤科Drug-induced erythema (L27.004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Urticarial drug eruption is pruritic wheals from drug; stop culprit drug, antihistamines, systemic steroids if severe, monitor anaphylaxis.
皮肤科Erythroderma-type drug eruption (L27.002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Epidermolysis-bullosa-type drug eruption (L27.000x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Exfoliative-dermatitis-type drug eruption is drug-induced generalized erythroderma; stop culprit drug, emollients, systemic steroids, monitor sepsis/fluid loss, identify cause.
皮肤科Drug eruption (dermatitis medicamentosa) (L27.000x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Generalized rash due to drugs/medicaments (L27.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being co
Hebra pityriasis (pityriasis rubra) (L26.x01) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Neonatal exfoliative dermatitis (L26.x00x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Exfoliative dermatitis (erythroderma) is generalized red scaly dermatitis from psoriasis/drug/atopic/lymphoma; emollients, topical/systemic steroids, treat cause, monitor fluid/protein loss, infection.
皮肤科Occupational dermatosis (L25.900x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|